Evidence map›Paper›PMID 29866990›Full record

ArticleJournal of fungi (Basel, Switzerland)2018

An In Vitro Model for

Daniel Montelongo-Jauregui, Anand Srinivasan, Anand K Ramasubramanian, Jose L Lopez-Ribot

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Microbial Biofilm Decontamination on Dental Implant Surfaces: A Mini Review.Frontiers in cellular and infection microbiology · 2021
    Pooled it
  2. The Prevalence and Drug Susceptibility ofAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. The Impact ofInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Review
  8. Polymicrobial Biofilm Dynamics of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  9. Review
  10. Review
  11. Cross-kingdom interaction betweenFrontiers in microbiology · 2022
    Review
  12. Recent Advances and Opportunities in the Study ofFrontiers in cellular and infection microbiology · 2022
    Review
  13. Interactions betweenFrontiers in microbiology · 2022
    Review
  14. Article
  15. The Role ofFrontiers in cellular and infection microbiology · 2021
    Review
  16. Article
  17. Article
  18. Oral Candidiasis: A Disease of Opportunity.Journal of fungi (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Candida Interactions with the Oral Bacterial Microbiota.Journal of fungi (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniel Montelongo-JaureguiDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX 78249, USA. Daniel.Montelongo@utsa.edu.
Anand SrinivasanResearch and Development, BioBridge Global, San Antonio, TX 78201, USA. anand.srinivasan@live.com.
Anand K RamasubramanianDepartment of Biomedical, Chemical, and Materials Engineering, San Jose State University, San Jose, CA 95192, USA. anand.ramasubramanian@sjsu.edu.
Jose L Lopez-RibotDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX 78249, USA. jose.lopezribot@utsa.edu.
Texas Center for Infectious Disease · USSan Jose State University · US

Funding

Development of novel chemical series of Candida albicans biofilm inhibitorsR01AI119554 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L., MCHARDY, STANTON FURST · 2015 to 2019
$1.8M
Targeting virulence against oral candidiasis in HIV/AIDSR01DE023510 · NIDCR · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2013 to 2017
$1.8M
NIAID NIH HHS R01 AI119554NIDCR NIH HHS R01 DE023510
6 · The paper itself

Abstract

The oral cavity serves as a nutrient-rich haven for over 600 species of microorganisms. Although many are essential to maintaining the oral microbiota, some can cause oral infections such as caries, periodontitis, mucositis, and endodontic infections, and this is further exacerbated with dental implants. Most of these infections are mixed species in nature and associated with a biofilm mode of growth. Here, after optimization of different parameters including cell density, growth media, and incubation conditions, we have developed an in vitro model of

Indexed as

Candida albicansmixed biofilmsStreptococcus gordoniisynthetic salivatitanium alloy

Identifiers

PMID29866990
PMCPMC6023327
OpenAlexW2807113217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.